Answers are grounded in this paper and cite their sources.
Identifying BAP1 Targets Inactivating mutations in the deubiquitinating enzyme BAP1 have been associated with cancer. Dey et al. (p. 1541 , published online 9 August; see the Perspective by White and Harper ) reveal molecular targets of the enzyme and show evidence for a role in leukemia. Mice specifically lacking the target of BAP1, HCF-1, in the bone marrow developed myeloid leukemia. BAP1 appears to be part of a complex that regulates modification of histones and gene expression important for normal hematopoiesis and tumor suppression.
No takes yet. Share an insight, caveat, or question.
Dey et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: